Charles River Laboratories International Investors
Charles River Laboratories International provides research models and outsourced preclinical services for the accelerated R&D of drugs.
Total Funding:
1534000000.0
Acquisitions Number:
32
Headquarters:
Wilmington, Massachusetts, United States
Funding Status:
IPO
Employee Number:
5001-10000
Estimated Revenue:
$500M to $1B
Last Funding Type:
Post-IPO Debt
Number Of Exists:
1
Technology:
Drug Delivery
Last Funding Date:
2021-03-23
Investors Number:
1.0
Founded Date:
1947-01-01
Industry:
Early Drug Development